Randomized Double Blind Placebo Controlled Study of the Safety & Efficacy of Therapeutic Treatment With AlloRx Stem Cells® in Patients With Pitt Hopkins Syndrome (Phase 1/2 Study)
Latest Information Update: 07 Dec 2023
At a glance
- Drugs Umbilical cord-derived allogeneic mesenchymal stem cell therapy-Vitro Biopharma (Primary)
- Indications Pitt-Hopkins syndrome
- Focus Adverse reactions
- Sponsors Vitro Diagnostics
Most Recent Events
- 19 Oct 2022 According to a FUJIFILM Corporation media release, PRIME-XV Stem FreezIS DMSO-Free cryopreservation medium will be to be used as an excipient in the trial.
- 30 Dec 2021 New trial record